Radiology Doctors in Kirkland, WA Accepting Medicare

8 Radiology doctors found. Showing 1 - 8

Dr. Richard E. Miller, MD Radiology - Diagnostic Radiology Medicare: Medicare Enrolled Practice Location: 12016 87th Ave Ne, Kirkland, WA 98034 Phone: 425-820-1314

Dr. Dara Omer, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 12040 Ne 128th St, Kirkland, WA 98034 Phone: 425-899-1800

Dr. Mark A. Skirgaudas, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 11811 Ne 128th Street, Kirkland, WA 98034 Phone: 425-821-3472    Fax: 425-820-4115

Dr. Andrea Marie Winter, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 12040 Ne 128th St, Kirkland, WA 98034 Phone: 425-899-1800    Fax: 425-899-1804

Rosanna Hoi Lam Yeung, M.D. Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 12040 Ne 128th St # Ms -63, Kirkland, WA 98034 Phone: 425-899-1860    Fax: 425-899-1859

Dr. Harold E. Olsson, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 12040 Ne 128th St, Evergreen Hospital Medical Center, Kirkland, WA 98034 Phone: 425-899-2000

Eric William Taylor, MD Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 12040 Ne 128th St # 63, Kirkland, WA 98034 Phone: 425-899-1860    Fax: 425-899-1859

Dr. Davis Alan Guilbert, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 11811 Ne 128th Street, Kirkland, WA 98034 Phone: 425-821-3472    Fax: 425-820-4115

News Archive

AUL distributes copies of recent report, 'The Case for Investigating Planned Parenthood'

Americans United for Life today renewed the call for a Congressional investigation and released an analysis and point-by-point rebuttal of Planned Parenthood's "Fact-Check" of AUL's recent report.

FDA grants orphan drug status to Provectus' PV-10 for liver cancer treatment

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has received orphan drug designation by the U.S. Food and Drug Administration for Rose Bengal, the active ingredient in its novel oncology drug PV-10, for the treatment of hepatocellular carcinoma, the most common form of primary liver cancer.

Children in poverty have smaller volumes of certain subcortical brain regions, study finds

Children in poverty are more likely to have cognitive and behavioral difficulties than their better-off peers. Plenty of past research has looked into the physical effects of childhood poverty, or documented mental health disparities between socioeconomic classes.

Cytheris initiates ORVACS Phase II clinical trial to study HIV infection

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of Phase II clinical trial of the company's investigative immunomodulatory agent, CYT107 (rhIL-7), in combination with two potent antiretroviral drugs represented by the integrase inhibitor raltegravir (ISENTRESS- Merck & Co.) and the CCR5 inhibitor, maraviroc (SELZENTRY- ViiV Healthcare).

Read more Medical News

› Verified 3 days ago